A synthetic peptide for use as a blocking control in assays to test for specificity of LCA5 antibody, Alternative Names: LCA5 control peptide, LCA5 antibody Blocking Peptide, Anti-LCA5 Blocking Peptide, Leber Congenital Amaurosis 5 Blocking Peptide, C6orf152 Blocking Peptide, LCA5, LCA-5, LCA 5, LCA-5 Blocking Peptide, LCA 5 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
LCA5
(Leber Congenital Amaurosis 5 (LCA5))
Hintergrund
LCA5 is a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Mutations in this gene cause Leber congenital amaurosis type V. Alternative splicing results in two transcript variants.